New Disinfectant QASc - Completely new quaternary ammonium salts, substances with a broad-spectrum effect.

Summary of the technology

Currently, the incidence of bacteria resistance to antimicrobial agents such as antibiotics, but also commonly used disinfectants, becomes an issue in the field of disinfection. In many cases, multidrug-resistant strains to both groups of anti-infectives compounds were described. This trend results from the long-term use of antibiotics and disinfectants, especially in hospitals where bacteria are constantly exposed to the selection pressure of antibiotics and thus the bacteria are able to develop resistance to antimicrobials due to evolutionary mechanism.

We have prepared completely new substances with a broad spectrum effect: high antimicrobial potential against bacteria (EN 13727 + A2), mycobacteria (EN 14348), fungi (EN 13624) and enveloped viruses (EN 14476 + A2). Substance is significantly effective even at very low concentration.

Advantages
Effective at low concentration (0,06%):
• low production costs
• low allergy potential
• friendly to surfaces
• waste-water friendly

Potential Applications
• healthcare
• agriculture
• food industry

University Hospital Hradec Králové
University Hospital Hradec Králové

Details of the Technology Offer

Technology is owned by University Hospital Hradec Králové. Compounds were tested and certified according to EN standards. The development was supported by the Technology Agency of the Czech Republic within the programme for applied research, experimental development and Innovation GAMA 2 – Project TP01010034 – Centre for Transfer of Biomedical Technologies – PoC2. Czech patent 309 377 is granted. Some compounds hasn't been published yet. Centre for Transfer of Biomedical Technologies is now looking for a licencee ideally from the group of already established disinfectant manufacturerswho are experienced in registering new biocides and also have a global reach, thus offsetting the high costs of registration.

Intellectual property status

Granted Patent

Patent number : 309 377

Where : Czech Republic

Current development status

Certified tests according to EN standards

Desired business relationship

Patent licensing

Related Keywords

  • bacteria
  • disinfection
  • healthcare
  • disinfectant
  • quas
  • ammoniumsalt

About University Hospital Hradec Králové

University Hospital Hradec Králové is now one of the largest medical facilities not only in Eastern Bohemia but also throughout the Czech Republic. It is a state-of-the-art facility spanning a wide range of medical fields and serves as a catchment center for approximately 1,000,000 inhabitants from all over the Czech Republic.

More than 41,000 patients are hospitalized every year at the hospital’s 39 workplaces, which include 24 departments and over 1370 beds, with approximately 715,000 outpatients treated annually. The most complex surgical procedures are performed and modern diagnostic and treatment technologies are used. This makes University Hospital Hradec Králové comparable with similar hospitals in Europe.

University Hospital is an important research and educational institution closely connected with the Faculty of Medicine in Hradec Králové.

University Hospital Hradec Králové

Never miss an update from University Hospital Hradec Králové

Create your free account to connect with University Hospital Hradec Králové and thousands of other innovative organizations and professionals worldwide

University Hospital Hradec Králové

Send a request for information
to University Hospital Hradec Králové

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support